QSAR modeling of the antimicrobial activity of peptides as a mathematical function of a sequence of amino acids
暂无分享,去创建一个
Andrey A. Toropov | Jovana B. Veselinovic | Aleksandar M. Veselinovic | Mariya A. Toropova | Dusica B. Stojanovic | D. Stojanovic | A. Toropov | A. Veselinović | J. Veselinovic | Mariya A. Toropova
[1] L. Birnbaumer,et al. Heterotrimeric Gα(i) proteins are regulated by lipopolysaccharide and are anti-inflammatory in endotoxemia and polymicrobial sepsis. , 2011, Biochimica et biophysica acta.
[2] E. Ross,et al. A Gs-selective analog of the receptor-mimetic peptide mastoparan binds to Gs alpha in a kinked helical conformation. , 1997, Biochemistry.
[3] A. Pokorny,et al. Wasp mastoparans follow the same mechanism as the cell-penetrating peptide transportan 10. , 2009, Biochemistry.
[4] A. Milac,et al. More effective antimicrobial mastoparan derivatives, generated by 3D-QSAR-Almond and computational mutagenesis. , 2012, Molecular bioSystems.
[5] Andrey A Toropov,et al. SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] D. Devine,et al. In vitro susceptibility of the Streptococcus milleri group to antimicrobial peptides. , 2008, International endodontic journal.
[7] E. Krause,et al. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. , 1996, Biochemistry.
[8] Eduardo A. Castro,et al. QSAR treatment on a new class of triphenylmethyl-containing compounds as potent anticancer agents , 2011 .
[9] Kuo-Chen Chou,et al. Peptide reagent design based on physical and chemical properties of amino acid residues , 2007, J. Comput. Chem..
[10] Artem Cherkasov,et al. Application of 'inductive' QSAR descriptors for quantification of antibacterial activity of cationic polypeptides. , 2004, Molecules.
[11] S. Avram,et al. Evaluation of Antimicrobial Activity of New Mastoparan Derivatives Using QSAR and Computational Mutagenesis , 2011, International Journal of Peptide Research and Therapeutics.
[12] Pablo R Duchowicz,et al. A comparative QSAR on 1,2,5-thiadiazolidin-3-one 1,1-dioxide compounds as selective inhibitors of human serine proteinases. , 2011, Journal of molecular graphics & modelling.
[13] Y. Ohizumi,et al. Identification of a 97-kDa mastoparan-binding protein involving in Ca(2+) release from skeletal muscle sarcoplasmic reticulum. , 2000, Molecular pharmacology.
[14] Hiroshi Nikaido,et al. The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria , 2015, Clinical Microbiology Reviews.
[15] T. Niidome,et al. Interaction of mastoparan with membranes studied by 1H-NMR spectroscopy in detergent micelles and by solid-state 2H-NMR and 15N-NMR spectroscopy in oriented lipid bilayers. , 2001, European journal of biochemistry.
[16] M. Radu,et al. Mechanisms of Ceftazidime and Ciprofloxacin Transport through Porins in Multidrug-Resistance Developed by Extended-Spectrum Beta-Lactamase E.coli Strains , 2011, Journal of Fluorescence.
[17] Zong Dai,et al. QSAR modeling of peptide biological activity by coupling support vector machine with particle swarm optimization algorithm and genetic algorithm. , 2010, Journal of molecular graphics & modelling.
[18] M. Palma,et al. Investigating the effect of different positioning of lysine residues along the peptide chain of mastoparans for their secondary structures and biological activities , 2010, Amino Acids.
[19] M. Palma,et al. The effect of acidic residues and amphipathicity on the lytic activities of mastoparan peptides studied by fluorescence and CD spectroscopy , 2010, Amino Acids.
[20] R. Hancock,et al. Anti-endotoxin properties of cationic host defence peptides and proteins , 2005, Journal of endotoxin research.
[21] K. Brandenburg,et al. Endotoxins: relationship between structure, function, and activity. , 2010, Sub-cellular biochemistry.
[22] M. Palma,et al. Selectivity in the mechanism of action of antimicrobial mastoparan peptide Polybia-MP1 , 2008, European Biophysics Journal.
[23] H. Neu,et al. The Crisis in Antibiotic Resistance , 1992, Science.
[24] J. Barrett,et al. Antibiotics: where did we go wrong? , 2005, Drug discovery today.
[25] Andrey A Toropov,et al. CORAL software: prediction of carcinogenicity of drugs by means of the Monte Carlo method. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[26] S. Levy,et al. Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.
[27] P. Achary,et al. QSPR modelling of dielectric constants of π-conjugated organic compounds by means of the CORAL software , 2014, SAR and QSAR in environmental research.
[28] V. Čeřovský,et al. New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs , 2008, Peptides.
[29] A. Kowluru,et al. Mastoparan-induced insulin secretion from insulin-secreting betaTC3 and INS-1 cells: evidence for its regulation by Rho subfamily of G proteins. , 2003, Endocrinology.
[30] Victor I Band,et al. Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria , 2014, Antibiotics.
[31] Emilio Benfenati,et al. QSAR modeling of endpoints for peptides which is based on representation of the molecular structure by a sequence of amino acids , 2012, Structural Chemistry.